Effect of combined probiotic and vitamin D supplementation in treatment of coronary heart disease
Phase 3
- Conditions
- Coronary Heart Disease.Chronic ischaemic heart disease, unspecifiedI25.9
- Registration Number
- IRCT2017073033941N4
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Subjects aged 45-85 years
Diagnosed with type 2 diabetes and CHD
Exclusion Criteria
Taking vitamin D, probiotic and/or synbiotic within the last 3 months
Patients with thyroid disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method